Clinical effect of Peplomycin on recurrent breast cancer

Kimura, M.; Koida, T.; Fukuda, T.

Gan to Kagaku Ryoho. Cancer and ChemoTherapy 10(7): 1665-1669

1983


ISSN/ISBN: 0385-0684
PMID: 6191688
Document Number: 200779
Twelve patients with recurrent breast cancer were treated with Peplomycin monotherapy. Peplomycin was given intermittently with a dose of 10 mg intramuscularly twice a week. As side effects of Peplomycin, fever elevation in 75% (9/12), malaise in 67%, nausea and vomiting in 42%, anorexia in 42%, pulmonary toxicity in 8%, and loss of hair in 8%, were observed. Out of 8 evaluable cases, CR was obtained in 1, PR in 1, NC in 3, and PD in 3 cases, respectively.

Document emailed within 1 workday
Secure & encrypted payments